Endocrinology, Vol 103, 2137-2144, Copyright © 1978 by Endocrine Society

ARTICLES

Thyroxine 5'-deiodinase activity of rat kidney: observations on activation by thiols and inhibition by propylthiouracil

JL Leonard and IN Rosenberg

Enzymatic 5'-deiodination of T4 in various tissues is known to be stimulated by thiols and inhibited by propylthiouracil (PTU). Dithiothreitol (DTT) stimulation of rat kidney T4 5'-deiodinase followed saturation kinetics. Inhibition of the enzyme by PTU (10 (-5) M) was overcome in a concentration-dependent manner by DTT, methimazole (MMI), and thiourea. Pretreatment of catalytically active kidney microsomal preparations with PTS caused persistent inhibition of enzyme activity, assayed in the absence of PTU. Similarly, injection of PTU in rats in a dosage of 5 microgram/100 g BW or greater significantly impaired T4 5'-deiodination in subsequently isolated kidney microsomal preparations. Reagents that cleave disulfide bonds (DTT and KCN), as well as the reductant, Na2S2O4, and the thioureylene, MII, partially restored activity to PTU-inactivated enzyme in a time- and concentration-dependent way. These observations suggest that PTU inhibition of T4 5'-deiodinase results from an interaction of PTU with the enzym, possibly via a PTU-enzyme disulfide which can be prevented or reversed by thiols or thioureylene agents, and raise the possibility that protein sulfhydryl groups may undergo oxidation during the reductive 5'-deiodination of L-T4.

This article has been cited by other articles:

				F. S. Celi, G. Coppotelli, A. Chidakel, M. Kelly, B. A. Brillante, T. Shawker, N. Cherman, P. P. Feuillan, and M. T. Collins The Role of Type 1 and Type 2 5'-Deiodinase in the Pathophysiology of the 3,5,3'-Triiodothyronine Toxicosis of McCune-Albright Syndrome J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2383 - 2389. [Abstract] [Full Text] [PDF]

				A M Mitchell, M Tom, and R H Mortimer Thyroid hormone export from cells: contribution of P-glycoprotein J. Endocrinol., April 1, 2005; 185(1): 93 - 98. [Abstract] [Full Text] [PDF]

				J. L. Leonard, G. Simpson, and D. M. Leonard Characterization of the Protein Dimerization Domain Responsible for Assembly of Functional Selenodeiodinases J. Biol. Chem., March 25, 2005; 280(12): 11093 - 11100. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5452 - 5458. [Abstract] [Full Text] [PDF]

				W. Croteau, S. L. Whittemore, M. J. Schneider, and D. L. St. Germain Cloning and Expression of a cDNA for a Mammalian Type III Iodothyronine Deiodinase J. Biol. Chem., July 14, 1995; 270(28): 16569 - 16575. [Abstract] [Full Text] [PDF]

				J. Leonard, M. Kaplan, T. Visser, J. Silva, and P. Larsen Cerebral cortex responds rapidly to thyroid hormones Science, October 30, 1981; 214(4520): 571 - 573. [Abstract] [PDF]

				J. L. Leonard, T. J. Visser, and D. M. Leonard Characterization of the Subunit Structure of the Catalytically Active Type I Iodothyronine Deiodinase J. Biol. Chem., January 19, 2001; 276(4): 2600 - 2607. [Abstract] [Full Text] [PDF]

				G. Lian, L. Ding, M. Chen, Z. Liu, D. Zhao, and J. Ni Preparation and Properties of a Selenium-containing Catalytic Antibody as Type I Deiodinase Mimic J. Biol. Chem., July 20, 2001; 276(30): 28037 - 28041. [Abstract] [Full Text] [PDF]